X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (78) 78
oncology (78) 78
humans (67) 67
chemotherapy (41) 41
male (35) 35
female (33) 33
lung neoplasms - drug therapy (32) 32
carcinoma, non-small-cell lung - drug therapy (27) 27
lung cancer (27) 27
aged (25) 25
cancer (23) 23
middle aged (21) 21
mutation (21) 21
antineoplastic agents - therapeutic use (20) 20
lung cancer, non-small cell (20) 20
adult (19) 19
docetaxel (19) 19
lung neoplasms - genetics (19) 19
respiratory system (19) 19
antineoplastic combined chemotherapy protocols - therapeutic use (18) 18
immunotherapy (18) 18
tumors (17) 17
care and treatment (16) 16
carcinoma, non-small-cell lung - genetics (15) 15
metastasis (15) 15
non-small cell lung cancer (15) 15
open-label (15) 15
patients (15) 15
hematology, oncology and palliative medicine (14) 14
lung neoplasms - pathology (14) 14
nivolumab (14) 14
survival (14) 14
aged, 80 and over (13) 13
prognosis (13) 13
settore med/06 - oncologia medica (13) 13
non-small cell lung carcinoma (12) 12
nsclc (12) 12
therapy (12) 12
cell lung-cancer (11) 11
disease-free survival (11) 11
gefitinib (11) 11
immunohistochemistry (11) 11
multicenter (11) 11
adenocarcinoma (10) 10
antibodies, monoclonal - therapeutic use (10) 10
antibodies, monoclonal, humanized (10) 10
apoptosis (10) 10
cancer therapies (10) 10
clinical trials (10) 10
colorectal neoplasms - drug therapy (10) 10
erlotinib (10) 10
medicine, general & internal (10) 10
platinum (10) 10
safety (10) 10
treatment outcome (10) 10
analysis (9) 9
antineoplastic agents - adverse effects (9) 9
diagnosis (9) 9
growth-factor receptor (9) 9
pembrolizumab (9) 9
protein kinase inhibitors - therapeutic use (9) 9
resistance (9) 9
abridged index medicus (8) 8
animals (8) 8
cetuximab (8) 8
cisplatin (8) 8
double-blind (8) 8
kras (8) 8
lung neoplasms - mortality (8) 8
receptor, epidermal growth factor - genetics (8) 8
trial (8) 8
carcinoma (7) 7
carcinoma, non-small-cell lung - mortality (7) 7
expression (7) 7
k-ras mutations (7) 7
lung cancer, small cell (7) 7
medicine & public health (7) 7
pd-l1 protein (7) 7
phase-iii trial (7) 7
proto-oncogene proteins p21 - genetics (7) 7
respiratory tract diseases (7) 7
1st-line treatment (6) 6
antineoplastic agents - pharmacology (6) 6
carcinoma, non-small-cell lung - pathology (6) 6
colorectal cancer (6) 6
immune checkpoint (6) 6
kaplan-meier estimate (6) 6
lung neoplasms - metabolism (6) 6
lung-cancer (6) 6
mutation - genetics (6) 6
quinazolines - therapeutic use (6) 6
research (6) 6
survival analysis (6) 6
1506 (5) 5
article (5) 5
atezolizumab (5) 5
bevacizumab (5) 5
biomarkers, tumor - analysis (5) 5
carboplatin (5) 5
carcinoma, non-small-cell lung - metabolism (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 02/2017, Volume 376, Issue 7, pp. 629 - 640
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 2, pp. 123 - 135
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 22, pp. 2078 - 2092
Journal Article
Journal Article
Journal Article
Lung Cancer, ISSN 0169-5002, 01/2020, Volume 139, pp. 13 - 17
Recent evidences show that early integration of palliative care (PC) with oncology has a positive impact on patients' quality of life, quality of care and... 
Referral criteria | Early palliative care | Outpatient palliative care | Lung cancer | Thoracic cancer
Journal Article
Oncogene, ISSN 0950-9232, 12/2018, Volume 37, Issue 50, pp. 6463 - 6476
Journal Article
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 3739 - 3739
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 1756-9966, 12/2018, Volume 37, Issue 1, pp. 302 - 14
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 3025 - 3025
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2018, Volume 379, Issue 11, pp. e18 - 2092
To the Editor: In the KEYNOTE-189 trial, Gandhi et al. (May 31 issue) 1 compared pembrolizumab plus chemotherapy with chemotherapy alone in patients with... 
MEDICINE, GENERAL & INTERNAL | Chemotherapy | Pembrolizumab | Lung cancer | PD-L1 protein | Apoptosis
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 9005 - 9005
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2017, Volume 35, Issue 7_suppl, pp. 67 - 67
67 Background: Immune checkpoints inhibitors have clearly improved patients’outcomes in different tumors, but definitive predictive biomarkers are still... 
Journal Article
FUTURE ONCOLOGY, ISSN 1479-6694, 08/2019, Volume 15, Issue 23, pp. 2743 - 2757
Aim: A minority of patients gains advantage from immunotherapy (IO). Predictive variables of long-term benefit (LTB) are incompletely understood. Materials &... 
MULTICENTER | MONOTHERAPY | survival | OPEN-LABEL | DOCETAXEL | CHEMOTHERAPY | long-term benefit | disease response | PEMBROLIZUMAB | INHIBITION | ONCOLOGY | immunotherapy | NIVOLUMAB | LIGAND 1 | non-small-cell lung cancer
Journal Article